JankovicV1, Main, Merge, indexHead, Idat.i

Index : Idat.i

Les termes de plus forte occurence

3	0885-3185:2001:Shahed J:re:emergence:of
3	0885-3185:2001:Ondo W:thalamic:deep:brain
3	0885-3185:1999:Ondo W:a:novel:sublingual
3	0885-3185:1999:Jankovic J:movement:and:reaction
3	0022-510X:1999:Jankovic J:levodopa:induced:dyskinesias
3	0022-3085:2006:Pahwa R:long:term:evaluation
3	0022-3050:1999:Jankovic J:re:emergent:tremor
3	0006-8950:2000:Roberts Warrior D:postural:control:in
2	1364-6745:2009:Mata I:lrrk:r:g
2	1353-8020:2001:Jankovic J:dystonia:and:parkinsonism
2	1351-5101:2006:Winkelman J:considering:the:causes
2	1351-5101:2006:Horstink M:review:of:the
2	1172-7047:2007:Jankovic J:medical:management:of
2	1170-229X:2001:Le W:are:dopamine:receptor
2	1061-4036:2003:Le W:mutations:in:nr
2	0964-6906:2003:Li Y:glutathione:s:transferase
2	0885-3185:2011:Skodda S:instability:of:syllable
2	0885-3185:2011:Fekete R:revisiting:the:relationship
2	0885-3185:2011:Baizabal Carvallo J:diagnosis:and:treatment
2	0885-3185:2010:Okun M:reply:based:on
2	0885-3185:2010:Mostile G:correlation:between:kinesia
2	0885-3185:2009:Ravina B:the:course:of
2	0885-3185:2008:Wu L:applause:sign:in
2	0885-3185:2008:Schmidt C:autonomic:dysfunction:in
2	0885-3185:2008:Olanow C:a:randomized:double
2	0885-3185:2008:Kuo S:bilateral:pedunculopontine:nuclei
2	0885-3185:2008:Goetz C:movement:disorder:society
2	0885-3185:2007:Ishihara L:screening:for:lrrk
2	0885-3185:2007:Goetz C:movement:disorder:society
2	0885-3185:2006:Ondo W:subthalamic:deep:brain
2	0885-3185:2006:Higgins J:hs:bp:gene
2	0885-3185:2006:Ashour R:joint:and:skeletal
2	0885-3185:2005:Widnell K:role:of:comt
2	0885-3185:2005:Waters C:other:pharmacological:treatments
2	0885-3185:2005:Olanow C:neuroprotective:therapy:in
2	0885-3185:2005:Metman L:role:of:surgery
2	0885-3185:2005:Jankovic J:motor:fluctuations:and
2	0885-3185:2005:Adler C:nonmotor:complications:in
2	0885-3185:2003:Marshall V:role:of:dopamine
2	0885-3185:2003:Hill A:treatment:of:hypophonia
2	0885-3185:2002:Ondo W:olanzapine:treatment:for
2	0885-3185:1999:Wali G:shoulder:girdle:dyskinesia
2	0885-3185:1997:Krauss J:improvement:of:parkinsonian
2	0885-3185:1994:Olanow C:a:multicenter:double
2	0885-3185:1993:Jankovic J:what:is:it
2	0885-3185:1989:Jankovic J:comparison:of:sinemet
2	0885-3185:1989:Fitzgerald P:lower:body:parkinsonism
2	0733-8619:1992:Stacy M:differential:diagnosis:of
2	0364-5134:2012:Goldman S:head:injury:alpha
2	0364-5134:2010:Stocchi F:initiating:levodopa:carbidopa
2	0364-5134:1986:Jankovic J:parkinson:s:disease
2	0364-5134:1985:Jansson B:low:cancer:rates
2	0364-5134:1985:Geraghty J:association:between:essential
2	0362-5664:1987:Jankovic J:coexistent:tardive:dyskinesia
2	0362-5664:1985:Jankovic J:long:term:use
2	0304-3940:2001:Tan E:alcohol:dehydrogenase:polymorphism
2	0303-8467:2007:Erer S:hereditary:chin:tremor
2	0300-9564:2001:Hanna P:switching:from:pergolide
2	0195-9131:1999:Stanley R:exercise:performance:in
2	0190-9622:1997:Pfutzner W:malignant:melanoma:and
2	0165-6147:1997:Mercuri N:electrophysiological:pharmacology:of
2	0165-6147:1997:Hagan J:parkinson:s:disease
2	0148-396X:2003:Sanghera M:basal:ganglia:neuronal
2	0148-396X:1995:Jankovic J:outcome:after:stereotactic
2	0098-7484:2001:Scott W:complete:genomic:screen
2	0098-7484:2001:Martin E:association:of:single
2	0093-0415:1996:Ng D:parkinson:s:disease
2	0093-0415:1989:Markham C:optimal:drug:management
2	0091-3952:2001:Jankovic J:effects:of:pallidotomy
2	0091-3952:1997:Jankovic J:thalamic:surgery:for
2	0066-4219:1993:Stacy M:current:approaches:in
2	0028-3878:2007:Ravina B:the:impact:of
2	0028-3878:2002:Xu P:association:of:homozygous
2	0028-3878:2002:Jankovic J:levodopa:strengths:and
2	0028-3878:2001:Ondo W:daytime:sleepiness:and
2	0028-3878:2001:Giladi N:freezing:of:gait
2	0028-3878:2000:Tan E:variability:and:validity
2	0028-3878:2000:Tan E:polymorphism:of:nacp
2	0028-3878:2000:Lai E:long:term:efficacy
2	0028-3878:2000:Jankovic J:essential:tremor:clinical
2	0028-3878:2000:Jankovic J:complications:and:limitations
2	0028-3878:1998:Ondo W:unilateral:thalamic:deep
2	0028-3878:1998:Ondo W:assessment:of:motor
2	0028-3878:1995:Jankovic J:tremor:and:longevity
2	0028-3878:1994:Jankovic J:early:stage:parkinson
2	0028-3878:1990:Jankovic J:variable:expression:of
2	0028-3878:1989:Jankovic J:clinical:biochemical:and
2	0028-3878:1985:Zetusky W:the:heterogeneity:of
2	0028-3878:1985:Spitz M:familial:tic:disorder
2	0028-3878:1985:Jankovic J:placebo:controlled:study
2	0028-3878:1985:Jankovic J:long:term:study
2	0028-3878:1985:Jankovic J:late:onset:hallervorden
2	0022-510X:2009:York M:relationship:between:neuropsychological
2	0022-510X:2007:Tan E:comparing:knowledge:and
2	0022-510X:2007:Diamond A:the:effects:of
2	0022-510X:2004:Thomas M:clinical:gait:and
2	0022-3085:2007:Kenney C:short:term:and
2	0022-3085:1998:Desaloms J:posteroventral:medial:pallidotomy
2	0022-3085:1997:Krauss J:microelectrode:guided:posteroventral
2	0022-3050:2011:Jankovic J:diagnosis:and:treatment
2	0022-3050:2010:Ferrara J:impact:of:stn
2	0022-3050:2008:York M:cognitive:declines:following
2	0022-3050:2008:Jankovic J:parkinson:s:disease
2	0022-3050:2005:Ondo W:modafinil:for:daytime
2	0022-3050:2005:Diamond A:the:effect:of
2	0022-3050:2000:Rettig G:neuropsychological:outcome:after
2	0022-3050:1998:Wenning G:natural:history:and
2	0022-3050:1998:Sankhla C:peripherally:induced:oromandibular
2	0022-3050:1997:Federico F:proton:magnetic:resonance
2	0022-3050:1996:Steiger M:disordered:axial:movement
2	0022-3050:1996:Ben Shlomo Y:how:far:are
2	0022-3050:1995:Nielsen J:hereditary:haemochromatosis:a
2	0022-3050:1995:Factor S:psychogenic:movement:disorders
2	0022-3050:1995:Caparros Lefebvre D:which:factors:predict
2	0022-3050:1994:Vidakovi A:hemiballism:report:of
2	0022-3050:1994:Rodriguez M:reflex:myoclonus:in
2	0022-3050:1993:Bain P:assessing:tremor:severity
2	0022-3050:1992:Foster N:progressive:subcortical:gliosis
2	0022-3050:1991:Mouradian M:comparison:of:the
2	0022-3050:1990:Jankovic J:botulinum:toxin:treatment
2	0022-3050:1989:Pillon B:does:cognitive:impairment
2	0022-3050:1989:Gibb W:neuropathology:in:movement
2	0022-3050:1989:Fahn S:clinical:variants:of
2	0022-3050:1988:Hietanen M:the:effect:of
2	0022-3050:1988:Factor S:parkinson:s:disease
2	0022-3050:1985:Maher E:cognitive:deficits:in
2	0022-3050:1984:Rajput A:essential:tremor:in
2	0014-4886:1999:Le W:selective:agenesis:of
2	0003-9942:2007:Jankovic J:transdermal:rotigotine:double
2	0003-9942:2006:Tan E:genetic:testing:in
2	0003-9942:2005:Tintner R:pleuropulmonary:fibrosis:after
2	0003-9942:2003:Oliveira S:association:study:of
2	0003-9942:2002:Ondo W:exploring:the:relationship
2	0003-9942:2001:Ondo W:thalamic:deep:brain
2	0003-9942:2001:Jankovic J:functional:decline:in
2	0003-9942:2000:Ondo W:computerized:posturography:analysis
2	0003-9942:2000:Jankovic J:the:evolution:of
2	0003-9942:1999:Winikates J:clinical:correlates:of
2	0003-9942:1999:Le W:effects:of:cerebrospinal
2	0003-9942:1999:Jankovic J:new:and:emerging
2	0003-9942:1999:Hanna P:multiple:system:atrophy
2	0003-9942:1998:Wang W:the:g:a
2	0003-9942:1998:Litvan I:accuracy:of:the
2	0003-9942:1997:Litvan I:what:is:the
2	0003-9942:1997:Krauss J:posteroventral:medial:pallidotomy
2	0003-9926:2003:Simpkins N:neuroprotection:in:parkinson
2	0003-2999:1996:Krauss J:propofol:induced:dyskinesias
2	0002-9297:2003:Van Der Walt J:mitochondrial:polymorphisms:significantly
2	0002-9297:2002:Li Y:age:at:onset
2	0001-6314:2009:Deng H:examination:of:the
2	0001-6314:2005:Deng H:g:d:and
1	2324-9269:2015:Foroud T:novel:recruitment:strategy
1	2314-6133:2013:Greg Rio M:impact:of:genetic
1	2234-0645:2015:Ye B:correction:of:camptocormia
1	2193-8253:2012:Ferrara J:effect:of:tetrabenazine
1	2168-6149:2013:Kang J:association:of:cerebrospinal
1	2162-3279:2015:Yu F:patterns:of:gray
1	2162-3279:2014:Dieb W:lesion:of:the
1	2158-0014:2013:Beall E:the:effect:of
1	2093-7911:2013:Park R:neurobehavioral:deficits:and
1	2090-8083:2015:Xu Y:the:natural:history
1	2090-8083:2013:Bugalho P:predictors:of:cognitive
1	2090-8083:2012:Bonnet A:nonmotor:symptoms:in
1	2008-126X:2013:Mahdavi R:the:effects:of
1	1933-7213:2013:Le W:animal:models:of
1	1933-7213:2013:Galpern W:designing:clinical:trials
1	1933-7213:2013:Factor S:editorial:neurotherapeutics:of
1	1933-7213:2010:Rappold P:astrocytes:and:therapeutics
1	1933-7213:2008:Jinnah H:experimental:therapeutics:for
1	1871-5273:2009:Johnson K:glutamate:receptors:as
1	1862-8346:2008:Kitsou E:identification:of:proteins
1	1862-8346:2008:Caudle W:proteomic:identification:of
1	1862-8346:2007:Bermudez Respo J:a:better:understanding
1	1807-5932:2014:Liu K:clinical:profile:of
1	1757-4676:2014:Proschel C:delayed:transplantation:of
1	1757-4676:2009:Deas E:pink:function:in
1	1756-8919:2009:Hopkins C:mglur:positive:allosteric
1	1756-2856:2009:Sujith O:therapeutic:options:for
1	1755-1471:2008:Lee H:g:protein:coupled
1	1752-9816:2010:Suddick K:the:lived:experience
1	1741-2560:2010:Tass P:the:causal:relationship
1	1673-1581:2011:Liu P:clinical:heterogeneity:in
1	1664-5464:2015:Petrova M:clinical:and:neuropsychological
1	1662-4548:2016:Obeso I:the:effectiveness:of
1	1662-4548:2016:Johnstone D:turning:on:lights
1	1662-4548:2015:Gallegos S:features:of:alpha
1	1662-4548:2015:De Dreu M:partnered:dancing:to
1	1615-9853:2010:Schroder B:the:proteome:of
1	1615-9853:2010:Opsahl J:increased:interaction:between
1	1612-1872:2009:Kr Mer S:the:biochemistry:of
1	1570-159X:2013:Schneider S:genetics:and:pathophysiology
1	1570-159X:2007:Inamdar N:parkinson:s:disease
1	1568-0266:2009:Leverenz J:cognitive:impairment:and
1	1567-5769:2001:Brunet L:nitric:oxide:in
1	1567-2050:2008:Uversky V:amyloidogenesis:of:natively
1	1566-2772:2001:Wong D:in:vivo:imaging
1	1566-2772:2001:Dowsey Limousin P:deep:brain:stimulation
1	1553-7390:2011:Do C:web:based:genome
1	1552-4868:2003:Schulze T:genetic:linkage:and
1	1552-4841:2011:Zubenko G:replacement:of:homologous
1	1552-4841:2011:Wu Y:genetic:analysis:of
1	1552-4841:2011:Chen C:atp:a:variability
1	1552-4841:2011:Burns L:replication:study:of
1	1552-4841:2010:Wu Y:genetic:analysis:of
1	1552-4841:2010:Pichler I:parkin:gene:modifies
1	1552-4841:2010:Marchani E:evidence:for:three
1	1552-4841:2010:Klebe S:lingo:is:not
1	1552-4841:2010:De Mena L:analysis:of:the
1	1552-4841:2009:Matsuzawa D:association:study:between
1	1552-4841:2008:De Marco E:alpha:synuclein:promoter
1	1552-4841:2007:Chen C:nuclear:receptor:nr
1	1552-4841:2006:Lee E:lrrk:g:s
1	1552-4841:2005:Tan E:functional:comt:variant
1	1552-4841:2005:Smith K:identification:and:characterization
1	1552-4841:2005:Martinez M:apolipoprotein:e:is
1	1552-4841:2005:Domschke K:association:analysis:of
1	1552-4841:2004:Ruano D:nr:a:and
1	1552-4841:2004:Raiford K:no:association:between
1	1552-4841:2003:Tan E:monoamine:oxidase:b
1	1552-4841:2003:Carmine A:nurr:promoter:polymorphisms
1	1552-4825:2011:Romdhane L:genetic:diseases:in
1	1552-4825:2009:Newbury D:mapping:of:partially
1	1552-4825:2009:Hendricks A:estimating:the:probability
1	1552-4825:2008:Zhang J:heritable:essential:tremor
1	1552-4825:2008:Aguilar D:a:quantitative:assessment
1	1552-4825:2004:Inzelberg R:onset:and:progression
1	1549-3296:2010:Bjugstad K:biocompatibility:of:poly
1	1549-1277:2013:Pichler I:serum:iron:levels
1	1545-9624:2009:Hobson A:validity:and:reliability
1	1539-1604:2009:Ploeger B:washout:and:delayed
1	1534-4320:2009:Chan J:correlation:among:joint
1	1532-0456:2010:Nelson M:effects:of:p
1	1532-0456:2008:Martin K:the:neurotoxic:effects
1	1527-6546:2006:Schutte D:chronic:dementing:conditions
1	1525-5050:2001:Tarsy D:deep:brain:stimulation
1	1478-3223:2011:Weissenborn K:parkinsonism:in:patients
1	1476-5810:2008:Matharoo All B:serum:biomarker:profiling
1	1474-4422:2008:Jankovic J:parkinson:s:disease
1	1474-4422:2005:Ashour R:striatal:deformities:of
1	1474-1776:2012:Corbett A:drug:repositioning:for
1	1474-1776:2011:Neef D:heat:shock:transcription
1	1474-1776:2011:Meissner W:priorities:in:parkinson
1	1472-9288:2001:Magnin M:surgical:control:of
1	1471-003X:2011:Collier T:ageing:as:a
1	1471-003X:2010:Khurana V:modelling:neurodegeneration:in
1	1471-003X:2008:Jenner P:molecular:mechanisms:of
1	1471-003X:2008:Breakefield X:the:pathophysiological:basis
1	1471-003X:2006:Youdim M:the:therapeutic:potential
1	1446-9235:2009:Nomura T:pathogenetic:heterogeneity:of
1	1444-1586:2009:Kwak Y:associated:conditions:and
1	1440-6381:2005:Mott S:sexual:limitations:in
1	1435-8603:2010:Ranganathan Y:reducing:the:babel
1	1434-6621:2011:Breen D:parkinson:s:disease
1	1431-6730:2006:Roder K:the:k:channel
1	1424-862X:2011:Wu Y:resveratrol:activated:ampk
1	1388-2457:2000:Strafella A:effects:of:chronic
1	1387-2877:2006:Abdi F:detection:of:biomarkers
1	1380-3395:2011:O Ourke J:the:trail:making
1	1368-5031:2010:Tsouli S:how:should:we
1	1364-6745:2010:Vilarino Guell C:lingo:and:lingo
1	1364-6745:2003:Simon D:a:heteroplasmic:mitochondrial
1	1364-6745:2001:Leung J:novel:mutation:in
1	1364-6745:1999:Scott W:the:alpha:synuclein
1	1359-6446:2007:Shi Y:orphan:nuclear:receptors
1	1359-4184:2012:Scharf J:genome:wide:association
1	1354-3784:2003:Tintner R:dopamine:agonists:in
1	1353-8020:2011:Williams A:cognitive:outcome:and
1	1353-8020:2011:Heldman D:essential:tremor:quantification
1	1353-8020:2009:Willis A:conjugal:parkinsonism:and
1	1353-8020:2009:Ledoux M:meige:syndrome:what
1	1353-8020:2008:Warren L:a:founding:lrrk
1	1353-8020:2008:Schneider M:minority:enrollment:in
1	1353-8020:2008:Blair M:reappraisal:of:the
1	1353-8020:2007:Vanvoorst W:neuropsychological:findings:in
1	1353-8020:2007:Shahed J:exploring:the:relationship
1	1353-8020:2002:Jankovic J:a:double:blind
1	1353-8020:2001:Weiner W:the:long:term
1	1353-8020:2001:Milanov I:a:cross:over
1	1353-8020:2001:Holmberg B:csf:neurofilament:and
1	1353-8020:2001:Askenasy J:approaching:disturbed:sleep
1	1353-8020:2000:Schiess M:parkinson:s:disease
1	1353-8020:2000:Milanov I:clinical:and:electromyographic
1	1353-8020:1999:Wszolek Z:molecular:genetics:of
1	1353-8020:1999:Sharma J:long:term:role
1	1353-8020:1999:Radojevic K:effect:of:unilateral
1	1353-8020:1999:Ort Pareja M:drug:induced:tardive
1	1353-8020:1999:Jenner P:genetic:susceptibility:and
1	1353-8020:1999:Foley P:mao:b:inhibitors
1	1353-8020:1998:Tall N Barranco A:clinical:features:of
1	1353-8020:1998:Revilla M:body:composition:in
1	1353-8020:1998:Rajrut A:amantadine:effectiveness:in
1	1353-8020:1998:Rajput A:epidemiology:of:parkinson
1	1353-8020:1998:Micheli F:delayed:onset:limb
1	1353-8020:1998:Bornstein N:cerebral:atherosclerosis:in
1	1353-8020:1997:Wszolek Z:rapidly:progressive:autosomal
1	1353-8020:1997:Wszolek Z:german:canadian:family
1	1353-8020:1997:Krauss J:tremor:and:dystonia
1	1353-8020:1997:Jimenez Jimenez F:delayed:onset:dystonia
1	1353-8020:1997:Hauser R:clinical:trials:of
1	1353-8020:1997:Chan J:idiopathic:cervical:dystonia
1	1353-8020:1997:Bongioanni P:t:lymphocyte:peripheral
1	1353-8020:1996:Wszolek Z:danish:american:family
1	1353-8020:1996:Nakajima Y:akinesia:and:axial
1	1353-8020:1996:Krauss J:ballism:not:related
1	1353-8020:1996:Khatter A:prevalence:of:tremor
1	1353-8020:1996:Jimenez Jimenez F:drug:induced:parkinsonism
1	1353-8020:1995:Wilhelmsen K:is:there:a
1	1353-8020:1995:Martinez Martin P:intermediate:scale:for
1	1353-8020:1995:Manji H:movement:disorders:in
1	1353-8020:1995:Denson M:familial:parkinsonism:our
1	1351-5101:2011:Wailke S:effect:of:controlled
1	1351-5101:2011:Peckham E:clinical:features:of
1	1351-5101:2011:Oka H:cardiovascular:dysautonomia:in
1	1351-5101:2011:Oh Y:color:vision:in
1	1351-5101:2011:Lorenzo Etancor O:lack:of:association
1	1351-5101:2011:Lorenz D:the:psychosocial:burden
1	1351-5101:2011:Chong R:rapid:assessment:of
1	1351-5101:2011:Becker C:nsaid:use:and
1	1351-5101:2010:Valko P:fatigue:and:excessive
1	1351-5101:2010:Tolosa E:cognition:in:essential
1	1351-5101:2010:Tan E:summary:of:gigyf
1	1351-5101:2010:Reichmann H:efficacy:and:tolerability
1	1351-5101:2010:Rawicki B:botulinum:toxin:assessment
1	1351-5101:2010:Raggi A:sleep:disorders:in
1	1351-5101:2010:Pont Unyer C:focal:limb:dystonia
1	1351-5101:2010:Olver J:botulinum:toxin:assessment
1	1351-5101:2010:Nyholm D:large:differences:in
1	1351-5101:2010:Jimenez Imenez F:impairment:of:rapid
1	1351-5101:2010:Graff Adford J:mood:and:motor
1	1351-5101:2010:Elia A:differential:diagnosis:of
1	1351-5101:2010:Costello S:familial:associations:of
1	1351-5101:2010:Barone P:neurotransmission:in:parkinson
1	1351-5101:2009:Wickremaratchi M:the:effect:of
1	1351-5101:2009:Schapira A:perspectives:on:recent
1	1351-5101:2009:Schapira A:levodopa:in:the
1	1351-5101:2009:Matinolli M:mobility:and:balance
1	1351-5101:2009:Jellinger K:handbook:of:clinical
1	1351-5101:2008:Tan E:hunting:for:genes
1	1351-5101:2008:Schapira A:progress:in:neuroprotection
1	1351-5101:2008:Martinez C:glutathione:s:transferase
1	1351-5101:2008:Lyros E:does:motor:subtype
1	1351-5101:2008:An X:lrrk:gly:arg
1	1351-5101:2007:Ramirez Uiz B:cerebral:atrophy:in
1	1351-5101:2007:Linazasoro G:classical:parkinson:disease
1	1351-5101:2007:Heuser K:microvascular:decompression:for
1	1351-5101:2006:Montplaisir J:long:term:treatment
1	1351-5101:2006:Borroni B:primitive:reflex:evaluation
1	1351-5101:2005:Shang H:clinical:and:molecular
1	1351-5101:2005:Lee P:parkinsonism:as:an
1	1351-5101:2005:Kaynak D:sleep:and:sleepiness
1	1351-5101:2004:Papapetropoulos S:the:effect:of
1	1351-5101:2004:Jellinger K:vascular:cognitive:impairment
1	1351-5101:2004:Jellinger K:textbook:of:clinical
1	1351-5101:2004:Furumoto H:excessive:daytime:somnolence
1	1351-5101:2003:Papapetropoulos S:clinical:characteristics:of
1	1351-5101:2003:Frattali C:yes:no:reversals
1	1351-5101:2002:Schapira A:dopamine:agonists:and
1	1351-5101:2002:Poewe W:the:differential:diagnosis
1	1351-5101:2002:Olanow C:surgical:therapy:for
1	1351-5101:2002:Burn D:depression:in:parkinson
1	1351-5101:2002:Autere J:molecular:genetic:analysis
1	1351-5101:2001:Krack P:review:of:the
1	1351-5101:1996:Koller W:efficacy:and:safety
1	1351-5101:1996:Durif F:comparison:of:cerebral
1	1351-5101:1996:Boas J:the:levodopa:dose
1	1351-5101:1995:Tolosa E:progressive:supranuclear:palsy
1	1351-5101:1995:Tison F:the:pathophysiology:of
1	1351-5101:1995:D Olhaberriague L:movement:disorders:in
1	1351-5101:1994:Rohl A:the:relevance:of
1	1351-0711:2013:Harris M:head:injuries:and
1	1351-0711:2006:Fored C:parkinson:s:disease
1	1350-7540:2002:Tintner R:treatment:options:for
1	1328-8067:2004:Demiroren K:diagnostic:role:of
1	1180-4882:2007:Strome E:electroconvulsive:shock:enhances
1	1176-9092:2008:Hagerman R:treatment:of:fragile
1	1176-6328:2008:Mukhida K:neurosurgical:strategies:for
1	1176-6328:2008:Jankovic J:current:approaches:to
1	1176-6328:2007:Shapiro M:the:four:as
1	1176-6328:2005:Richard I:mood:fluctuations:in
1	1174-5878:2009:Ferrara J:epidemiology:and:management
1	1170-229X:2003:Tianhong Pan:potential:therapeutic:properties
1	1170-229X:2003:Pan T:potential:therapeutic:properties
1	1134-2072:2001:Tudur Prez I:movimientos:involuntarios:actualizacin
1	1130-1473:1999:Seijo F:valor:del:registro
1	1130-1473:1996:Teijeiro Amador J:sistema:automatizado:de
1	1099-498X:2004:Azzouz M:lentiviral:vectors:for
1	1094-7159:2011:Shih L:sustained:dyskinesias:following
1	1094-7159:2011:Kovacs S:central:effects:of
1	1094-7159:2011:Gill C:deep:brain:stimulation
1	1094-7159:2010:Park Y:a:comparison:of
1	1094-7159:2008:Morishita T:effect:of:subthalamic
1	1094-7159:2003:Visocchi M:neuromodulation:of:cerebral
1	1094-7159:2003:Stocchi F:clinical:and:pharmacological
1	1094-7159:2003:Simpson B:stimulation:for:pain
1	1094-7159:2003:Scerrati M:surgical:treatment:for
1	1094-7159:2003:Palombi M:spinal:cord:stimulation
1	1094-7159:2003:Molteni F:spasticity:the:global
1	1094-7159:2003:Lavra G:neuromodulation:and:health
1	1094-7159:2003:Lavano A:new:treatments:for
1	1094-7159:2003:Landi A:deep:brain:stimulation
1	1094-7159:2003:Iani D:the:pathophysiology:of
1	1094-7159:2003:Di Lazzaro V:deep:brain:stimulation
1	1094-7159:2003:Colicchio G:vagal:stimulation:for
1	1094-7159:2003:Cesaroni A:pns:peripheral:nerve
1	1094-7159:2003:Caputi F:neuromodulation:and:neuropathic
1	1091-4269:2002:Edwards E:depression:and:parkinson
1	1090-3801:2005:Armero P:comt:val:met
1	1090-3798:2001:Morrison P:paediatric:and:adult
1	1090-3798:2000:Morrison P:adult:and:paediatric
1	1087-0792:2000:Bader G:sleep:bruxism:an
1	1087-0792:1999:Rijsman R:secondary:periodic:limb
1	1082-7579:1997:Louis E:tremor:disorders:identification
1	1081-5589:2009:Leehey M:fragile:x:associated
1	1080-4013:1996:Johnson L:lesch:nyhan:syndrome
1	1080-4013:1995:Friedmann T:lesch:nyhan:disease
1	1079-5006:2004:Murray A:a:longitudinal:study
1	1079-5006:1999:Bennett D:dimensionality:of:parkinsonian
1	1076-0512:2004:Martinelli P:mohs:micrographic:surgery
1	1074-7931:2008:Stamey W:impulse:control:disorders
1	1073-8584:2009:Weidong Le:etiopathogenesis:of:parkinson
1	1073-6077:1996:Scahill L:nonstimulant:medications:in
1	1065-9471:2011:Focke N:individual:voxel:based
1	1065-9471:2009:Boesveldt S:advanced:time:series
1	1065-6995:2007:Fallahi Ichani M:in:vitro:differentiation
1	1059-7794:2013:Wang L:high:resolution:survey
1	1059-7794:2011:Kuhlenb Umer G:novel:genomic:techniques
1	1059-7794:2010:Tan E:multiple:lrrk:variants
1	1059-7794:2010:Nuytemans K:genetic:etiology:of
1	1059-7794:2009:Srinivasan B:whole:genome:survey
1	1059-7794:2009:Paisan Uiz C:lrrk:gene:variation
1	1059-7794:2009:Krejci P:molecular:pathology:of
1	1059-7794:2009:Brandon M:mitomaster:a:bioinformatics
1	1059-7794:2007:Tan E:pathogenic:mutations:in
1	1059-7794:2007:Lesage S:deletion:of:the
1	1059-7794:2006:Li Y:genetic:evidence:for
1	1059-7794:2004:Rademakers R:the:role:of
1	1055-0496:1997:Dhopesh V:can:cocaine:abuse
1	1054-139X:2000:Boehm K:diagnosis:and:management
1	1053-8569:2009:Tsiropoulos I:adverse:events:with
1	1053-8119:1999:Garraux G:comparison:of:impaired
1	1053-4296:2000:Cleeland C:cancer:related:symptoms
1	1053-1807:1994:Rauch R:mr:imaging:findings
1	1052-1372:2015:Demaagd G:parkinson:s:disease
1	1052-1372:2011:Alexander W:th:international:congress
1	1044-7431:2001:Wallen :orphan:nuclear:receptor
1	1044-7431:1992:Deutch A:regionally:specific:effects
1	1044-5463:2010:Lyon G:testing:tic:suppression
1	1041-2972:2007:Snyder C:the:patient:with
1	1034-4810:2011:Alessandri A:parents:know:best
1	1021-7770:2009:Ahmed S:metabolic:profiling:of
1	1015-6305:2010:Shi M:biomarkers:for:cognitive
1	1015-6305:2007:Leverenz J:proteomic:identification:of
1	1015-6305:2006:Blesch A:neurotrophic:factors:in
1	1015-6305:2003:Lee H:will:preventing:protein
1	1015-6305:2002:Betarbet R:mechanistic:approaches:to
1	1015-6305:2000:Manfredim G:the:role:of
1	1015-6305:1999:Buee L:comparative:biochemistry:of
1	1015-6305:1998:Jellinger K:senile:dementia:with
1	0987-7053:2001:Vercueil L:les:myoclonies:chez
1	0987-7053:2001:Thobois S:contributions:of:pet
1	0987-7053:2000:Cassim F:exploration:neurophysiologique:des
1	0987-7053:1994:Autret A:influence:du:sommeil
1	0969-9961:2011:Neychev V:the:functional:neuroanatomy
1	0969-9961:2009:Peterson D:convergent:evidence:for
1	0969-9961:2000:Zhang Y:oxidative:stress:and
1	0969-9961:2000:Herrera A:the:single:intranigral
1	0969-9961:1999:Liu H:a:comparative:study
1	0967-5868:2001:Peters S:vascular:parkinsonism:a
1	0967-5868:1996:Reid W:a:longitudinal:of
1	0967-5868:1996:Hely M:an:australian:multicentre
1	0967-3334:2012:Meigal A:linear:and:nonlinear
1	0964-6906:2010:Sha D:phosphorylation:of:parkin
1	0964-6906:2010:Lesage S:parkinson:s:disease
1	0964-6906:2010:Gegg M:mitofusin:and:mitofusin
1	0964-6906:2009:Lesage S:parkinson:s:disease
1	0964-6906:2009:Giovannone B:gigyf:gene:disruption
1	0964-6906:2009:Azeredo Da Silveira S:phosphorylation:does:not
1	0964-6906:2008:Weihofen A:pink:parkinson:mutations
1	0964-6906:2008:Van Der Zee J:chmp:b:c
1	0964-6906:2007:Thomas B:parkinson:s:disease
1	0964-6906:2007:Sundar P:two:sites:in
1	0964-6906:2006:Sim C:c:terminal:truncation
1	0964-6906:2006:Mizuta I:multiple:candidate:gene
1	0964-6906:2005:Shashidharan P:transgenic:mouse:model
1	0964-6906:2005:Rademakers R:high:density:snp
1	0964-6906:2004:Li Y:glutathione:s:transferase
1	0964-6906:2003:Pankratz N:genome:wide:linkage
1	0964-6906:2003:Macedo M:the:dj:l
1	0964-6906:2003:Levecque C:association:between:parkinson
1	0964-6906:2003:Itier J:parkin:gene:inactivation
1	0964-6906:2003:Huynh D:the:autosomal:recessive
1	0964-6906:1999:Farrer M:the:genetics:of
1	0964-6906:1999:Farrer M:a:chromosome:p
1	0964-2633:2008:Cornish K:the:fragile:x
1	0963-6897:1996:Shannon K:neural:transplantation:for
1	0963-6897:1995:Watts R:intrastriatal:cografts:of
1	0962-1083:2003:Froufe E:identification:of:reproductively
1	0960-5428:1997:Ajjan R:cytokines:and:thyroid
1	0959-9851:1993:Nee E:olfactory:dysfunction:in
1	0959-9851:1992:Durrieu G:parkinson:s:disease

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/corpus/Jankovic.storage/JankovicV1/Data/Main/Merge/Idat.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.19.
Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024

	Serveur d'exploration autour de Joseph Jankovic - Merge (Accueil) Index « Idat.i » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration autour de Joseph Jankovic - Merge (Accueil)Index « Idat.i » - tête de navigation

Index : Idat.i

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration autour de Joseph Jankovic - Merge (Accueil)

Index « Idat.i » - tête de navigation